Supplemental ReSultS Quantification of the association of ipla 2 b with the plasma membrane In the absence of MCP-1, only 4% of iPLA 2 b was associated with the peripheral cell membrane of polar, randomly migrating cells. In contrast, MCP-1 induced a statistically significant increase in the association of iPLA 2 b with the cell membrane. Interestingly, even nonpolar but MCP-1-treated monocytes showed a similar induction of iPLA 2 b recruitment to the cell membrane that was not significantly different from MCP-1-treated polar monocytes (Fig. S1, filled vs. black-hatched bar) .
Recovery of Bel-treated monocytes
To determine why racemic-BEL inhibited chemotaxis in vitro (Ridley, A.J., and A. Hall. 1992. Cell. 70:389-399) , but not in vivo (Fig. 7) , we explored whether this was caused by racemic-BEL lability during the 24 h after adoptive transfer. We tested whether the racemic-BEL effect was reversible because in the adoptive transfer model the monocytes were treated in vitro with racemic-BEL and transferred into recipient mice, and their migration to the peritoneum was measured 24 h later. For this experiment, monocytes were treated with racemic-BEL for 60 min, and then washed and incubated for various times before assessing chemotaxis to MCP-1 in vitro (Fig. S2) . The chemotactic response increased with the time of incubation subsequent to racemic-BEL removal, thus indicating that monocytes can recover their ability to migrate to MCP-1. This finding explains why racemic-BEL-treated monocytes migrated normally in the adoptive transfer model. aaCOCF 3 is not toxic, and aaCOCF 3 -treated monocytes do not recover from the inhibitory effect of aaCOCF 3 To evaluate whether reduced migration of AACOCF 3 -treated monocytes was caused by their poor viability after AACOCF 3 treatment, AACOCF 3 -treated cells were allowed to recover for 24 h, and then tested for their viability by dye exclusion and evaluated for chemotaxis to MCP-1. For this purpose, monocytes were treated with AACOCF 3 , washed, and incubated for an additional 24 h at 37°C. As shown in Fig. S3 A, AACOCF 3 -treated cells that were allowed to recover for 24 h displayed significantly reduced migration to MCP-1 compared with untreated monocytes. This reduced migration was similar to monocytes that were freshly treated with AACOCF 3 that were not allowed to recover, suggesting that unlike BEL, AACOCF 3 -treated cells do not recover from the inhibitory effect of the drug. As shown in Fig. S3 B, no significant difference was observed in the survival of untreated, AACOCF 3 -treated, or AACOCF 3 -treated monocytes after 24 h of recovery, suggesting that reduced migration of AACOCF 3 -treated monocytes was not caused by their poor survival. cpla 2 a-specific antisense ODns reduced expression of the enzyme in mouse monocytes/macrophages C57BL/6 mice (8 wk old) were challenged with thioglycolate for 72 h. Monocytes/macrophages were isolated from the peritoneal lavage. Cells were left untreated or treated with 10 mM cPLA 2 a sense or antisense ODNs for 24 h. Cell lysates were resolved in an 8% SDS-PAGE and analyzed for the presence of cPLA 2 a, as described in our previous study by Carnevale and Cathcart (Carnevale, K.A., and M.K. Cathcart. 2001. J. Immunol. 167:3414-3421) . cPLA 2 a antisense ODN-treated cells show reduced expression of the enzyme compared with No ODN-or cPLA 2 a sense ODN-treated cells, despite equal loading of protein as demonstrated by reprobing the same blot with tubulin ( Fig. S4) 
